Untargeted Metabolomics for Diagnosis, Monitoring, and Understanding the Pathophysiology of Inherited Metabolic Disorders
Journal of Inherited Metabolic Disease · 2026-01 · 49 (1)
DOI: 10.1002/jimd.70120 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 02.12.2025. Verfasst von Jonathan Martens und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecules and Materials, FELIX Laboratory, Radboud University, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Metabolomics, Metabolism, Inborn Errors, Metabolic Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Inherited metabolic disorders (IMDs) encompass a diverse and expanding group of rare diseases caused by genetic disruptions mainly in metabolic enzymes and transporters. Clinical diagnosis of IMDs presents significant challenges due to phenotypic heterogeneity, nonspecific symptoms, and the limited scope of current targeted biochemical assays typically available. Recent advances in mass spectrometry‐based untargeted metabolomics offer promising solutions to several of these challenges by simultaneous detection and relative quantification of thousands of metabolites, not relying on any prior hypotheses. With the expansion of genetic diagnostics via whole‐exome and whole‐genome sequencing, metabolic insights are often crucial for understanding the pathogenicity of genetic variants of unknown significance, often enabling a clear diagnosis for patients. This review details current applications of untargeted metabolomics in IMDs, including biomarker discovery and elucidation of previously unknown pathophysiological mechanisms. Successful examples of biomarker identification in well‐studied IMDs, such as pyridoxine‐dependent epilepsy and phenylketonuria, are highlighted to provide novel disease insights. Additionally, we address technical and interpretation challenges inherent to this methodology, particularly concerning metabolite identification, high‐dimensional data complexity, and limited patient numbers. Emerging analytical technologies and data analysis approaches are highlighted that are poised to mitigate these challenges in the upcoming years. Finally, we provide an outlook on future directions, emphasizing the complementary roles of targeted and untargeted metabolomics and the prospects for the identification of new therapeutic targets as well as therapy monitoring for the clinical management of IMDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Molecules and Materials, FELIX Laboratory, Radboud University, Nijmegen, the Netherlands.
- Department of Human Genetics, Translational Metabolic Laboratory, Radboud University Medical Centre, Nijmegen, the Netherlands.
- United for Metabolic Diseases (UMD), Nijmegen, the Netherlands.
- Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, the Netherlands.
ORCID-Profile: Jonathan Martens, Ron A Wevers, Purva Kulkarni
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Zitieren
APA
Martens, J., Engelke, U. F. H., Wevers, R. A., Lefeber, D. J., & Kulkarni, P. (2026). Untargeted Metabolomics for Diagnosis, Monitoring, and Understanding the Pathophysiology of Inherited Metabolic Disorders. Journal of Inherited Metabolic Disease, 49(1). https://doi.org/10.1002/jimd.70120
Vancouver
Martens J, Engelke UFH, Wevers RA, Lefeber DJ, Kulkarni P. Untargeted Metabolomics for Diagnosis, Monitoring, and Understanding the Pathophysiology of Inherited Metabolic Disorders. Journal of Inherited Metabolic Disease. 2026;49(1). doi:10.1002/jimd.70120
BibTeX
@article{Martens2026,
author = {Martens, Jonathan and Engelke, Udo F H and Wevers, Ron A and Lefeber, Dirk J and Kulkarni, Purva},
title = {Untargeted Metabolomics for Diagnosis, Monitoring, and Understanding the Pathophysiology of Inherited Metabolic Disorders},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
volume = {49},
number = {1},
doi = {10.1002/jimd.70120}
}
EUVIMED